USA - engelsk - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - terbutaline sulfate (unii: 576pu70y8e) (terbutaline - unii:n8onu3l3pg) - terbutaline sulfate 1 mg in 1 ml - terbutaline sulfate injection, usp is indicated for the prevention and reversal of bronchospasm in patients 12 years of age and older with asthma and reversible bronchospasm associated with bronchitis and emphysema. 1. prolonged tocolysis terbutaline sulfate has not been approved and should not be used for prolonged tocolysis (beyond 48-72 hours). in particular, terbutaline sulfate should not be used for maintenance tocolysis in the outpatient or home setting (see boxed warning: prolonged tocolysis ). 2. hypersensitivity terbutaline sulfate injection is contraindicated in patients known to be hypersensitive to sympathomimetic amines or any component of this drug product.

USA - engelsk - NLM (National Library of Medicine)

athenex pharmaceutical division, llc. - terbutaline sulfate (unii: 576pu70y8e) (terbutaline - unii:n8onu3l3pg) - terbutaline sulfate 1 mg in 1 ml - terbutaline sulfate injection is indicated for the prevention and reversal of bronchospasm in patients 12 years of age and older with asthma and reversible bronchospasm associated with bronchitis and emphysema. - prolonged tocolysis terbutaline sulfate has not been approved for and should not be used for prolonged tocolysis (beyond 48 to 72 hours). in particular, terbutaline sulfate should not be used for maintenance tocolysis in the outpatient or home setting [see boxed warning, prolonged tocolysis ]. - hypersensitivity terbutaline sulfate injection is contraindicated in patients known to be hypersensitive to sympathomimetic amines or any component of this drug product.

USA - engelsk - NLM (National Library of Medicine)

united biomedical inc., asia - terbutaline sulfate (unii: 576pu70y8e) (terbutaline - unii:n8onu3l3pg) - terbutaline sulfate 1 mg in 1 ml - terbutaline sulfate injection is indicated for the prevention and reversal of bronchospasm in patients 12 years of age and older with asthma and reversible bronchospasm associated with bronchitis and emphysema.

USA - engelsk - NLM (National Library of Medicine)

fresenius kabi usa, llc - terbutaline sulfate (unii: 576pu70y8e) (terbutaline - unii:n8onu3l3pg) - terbutaline sulfate 1 mg in 1 ml - terbutaline sulfate injection, usp is indicated for the prevention and reversal of bronchospasm in patients 12 years of age and older with asthma and reversible bronchospasm associated with bronchitis and emphysema. terbutaline sulfate has not been approved and should not be used for prolonged tocolysis (beyond 48 to 72 hours).  in particular, terbutaline sulfate should not be used for maintenance tocolysis in the outpatient or home setting (see boxed warning : prolonged tocolysis ). terbutaline sulfate injection is contraindicated in patients known to be hypersensitive to sympathomimetic amines or any component of this drug product.

USA - engelsk - NLM (National Library of Medicine)

medical purchasing solutions. llc - terbutaline sulfate (unii: 576pu70y8e) (terbutaline - unii:n8onu3l3pg) - terbutaline sulfate 1 mg in 1 ml - terbutaline sulfate injection, usp is indicated for the prevention and reversal of bronchospasm in patients 12 years of age and older with asthma and reversible bronchospasm associated with bronchitis and emphysema. 1. prolonged tocolysis terbutaline sulfate has not been approved and should not be used for prolonged tocolysis (beyond 48-72 hours). in particular, terbutaline sulfate should not be used for maintenance tocolysis in the outpatient or home setting (see boxed warning: prolonged tocolysis ). 2. hypersensitivity terbutaline sulfate injection is contraindicated in patients known to be hypersensitive to sympathomimetic amines or any component of this drug product.

USA - engelsk - NLM (National Library of Medicine)

akorn - terbutaline sulfate (unii: 576pu70y8e) (terbutaline - unii:n8onu3l3pg) - terbutaline sulfate 1 mg in 1 ml - terbutaline sulfate injection, usp is indicated for the prevention and reversal of bronchospasm in patients 12 years of age and older with asthma and reversible bronchospasm associated with bronchitis and emphysema. terbutaline sulfate has not been approved and should not be used for prolonged tocolysis (beyond 48 -72 hours). in particular, terbutaline sulfate should not be used for maintenance tocolysis in the outpatient or home setting. [see boxed warning, prolonged tocolysis .] terbutaline sulfate injection is contraindicated in patients known to be hypersensitive to sympathomimetic amines or any component of this drug product.

USA - engelsk - NLM (National Library of Medicine)

general injectables & vaccines, inc - terbutaline sulfate (unii: 576pu70y8e) (terbutaline - unii:n8onu3l3pg) - terbutaline sulfate 1 mg in 1 ml - terbutaline sulfate injection, usp is indicated for the prevention and reversal of bronchospasm in patients 12 years of age and older with asthma and reversible bronchospasm associated with bronchitis and emphysema. prolonged tocolysis terbutaline sulfate has not been approved and should not be used for prolonged tocolysis (beyond 48 to 72 hours). in particular, terbutaline sulfate should not be used for maintenance tocolysis in the outpatient or home setting (see boxed warning: prolonged tocolysis). hypersensitivity terbutaline sulfate injection is contraindicated in patients known to be hypersensitive to sympathomimetic amines or any component of this drug product.

USA - engelsk - NLM (National Library of Medicine)

medical purchasing solutions, llc - terbutaline sulfate (unii: 576pu70y8e) (terbutaline - unii:n8onu3l3pg) - terbutaline sulfate injection is indicated for the prevention and reversal of bronchospasm in patients 12 years of age and older with asthma and reversible bronchospasm associated with bronchitis and emphysema. - prolonged tocolysis terbutaline sulfate has not been approved for and should not be used for prolonged tocolysis (beyond 48 to 72 hours). in particular, terbutaline sulfate should not be used for maintenance tocolysis in the outpatient or home setting [see boxed warning, prolonged tocolysis ]. - hypersensitivity terbutaline sulfate injection is contraindicated in patients known to be hypersensitive to sympathomimetic amines or any component of this drug product.

USA - engelsk - NLM (National Library of Medicine)

ubi pharma inc. - terbutaline sulfate (unii: 576pu70y8e) (terbutaline - unii:n8onu3l3pg) - terbutaline sulfate injection is indicated for the prevention and reversal of bronchospasm in patients 12 years of age and older with asthma and reversible bronchospasm associated with bronchitis and emphysema. - prolonged tocolysis terbutaline sulfate has not been approved for and should not be used for prolonged tocolysis (beyond 48-72 hours). in particular, terbutaline sulfate should not be used for maintenance tocolysis in the outpatient or home setting. [see boxed warning: prolonged tocolysis.] - hypersensitivity terbutaline sulfate injection is contraindicated in patients known to be hypersensitive to sympathomimetic amines or any component of this drug product.

USA - engelsk - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - terbutaline sulfate (unii: 576pu70y8e) (terbutaline - unii:n8onu3l3pg) - terbutaline sulfate injection, usp is indicated for the prevention and reversal of bronchospasm in patients 12 years of age and older with asthma and reversible bronchospasm associated with bronchitis and emphysema. 1. prolonged tocolysis terbutaline sulfate has not been approved and should not be used for prolonged tocolysis (beyond 48-72 hours). in particular, terbutaline sulfate should not be used for maintenance tocolysis in the outpatient or home setting (see boxed warning: prolonged tocolysis ). 2. hypersensitivity terbutaline sulfate injection is contraindicated in patients known to be hypersensitive to sympathomimetic amines or any component of this drug product.